Hostname: page-component-6766d58669-kl59c Total loading time: 0 Render date: 2026-05-20T13:24:56.374Z Has data issue: false hasContentIssue false

In the Zone: lessons from the first Canadian emergency department application of resuscitative endovascular balloon occlusion of the aorta (REBOA)

Published online by Cambridge University Press:  17 January 2019

Markus T. Ziesmann
Affiliation:
Trauma and Acute Care Surgery, St Michael's Hospital Department of Critical Care, University of Toronto Department of Surgery, University of Toronto
Joao Rezende-Neto
Affiliation:
Trauma and Acute Care Surgery, St Michael's Hospital Department of Surgery, University of Toronto
Katherine McKendy
Affiliation:
Trauma and Acute Care Surgery, St Michael's Hospital Department of Surgery, University of Toronto
Vikramaditya Prabhudesai
Affiliation:
Department of Medical Imaging, St. Michael's Hospital, University of Toronto
Sandro Rizoli
Affiliation:
Trauma and Acute Care Surgery, St Michael's Hospital Department of Critical Care, University of Toronto Department of Surgery, University of Toronto
Andrew Petrosoniak*
Affiliation:
Department of Emergency Medicine, St Michael's Hospital, Toronto, ON Department of Medicine, University of Toronto
*
Correspondence to: Dr. Andrew Petrosoniak, St. Michael's Hospital, Department of Emergency Medicine, 30 Bond Street, Toronto, ON M5B 1W8; Email: petro82@gmail.com

Abstract

Information

Type
Clinical Correspondence
Copyright
Copyright © Canadian Association of Emergency Physicians 2019 
Figure 0

Figure 1. REBOA placement algorithm (A). Aortic zones of occlusion (B), adapted from Stannard, Eliason, and Rasmussen.9 Zone 1 between the left subclavian artery and celiac artery is the recommended location for suspected intra-abdominal hemorrhage; Zone 2 between the celiac arteries and renal arteries is not a recommended placement location; and Zone 3, from the lowest renal artery to the aortic bifurcation, is the recommended location for suspected pelvic hemorrhage. Following the decision to proceed with REBOA placement, the clinician must determine where to position the occlusive balloon (Figure 1A). In this case, the patient had a positive FAST, and following the algorithm in Figure 1A, we placed the device in Zone 1.

Figure 1

Table 1. Practical considerations for REBOA implementation

Figure 2

Table 2. REBOA indications and contraindications summarized from published literature

Supplementary material: File

Ziesmann et al. supplementary material

Table S1

Download Ziesmann et al. supplementary material(File)
File 19.7 KB